CLINICAL_TRIALS
research
· 2026-04-21
Clinical Trial Update: A Phase III Study of JR-141 in Patients With Mucopolysaccharidosis II (STARLIGHT) [Phase 3]
Summary
Phase III study evaluating JR-141 for mucopolysaccharidosis type II is currently active but not recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: JCR Pharmaceuticals Co., Ltd. | Conditions: Mucopolysaccharidosis II | Phase 3 | Status: ACTIVE_NOT_RECRUITING